This content is machine translated Screening for atrial fibrillation is not a sure-fire success Oral anticoagulation in AHRE risky and ineffective Anticoagulants increase the risk of bleeding but do not prevent strokes in patients with atrial high rate episodes (AHRE) and without ECG-diagnosed atrial fibrillation. This is the conclusion of the…
View Post 7 min This content is machine translated Secondary prevention after ischemic stroke Early aspirin treatment is very effective After ischemic stroke of noncardioembolic etiology: early aspirin treatment is extremely effective in preventing recurrence. Atrial fibrillation should be treated with one of the new oral anticoagulants because of the…
View Post 4 min This content is machine translated Anticoagulation Procedure for special patient groups Continuing postmenopausal hormone therapy or hormone-containing contraception in women on anticoagulation seems risky. After all, hormone-containing preparations increase the risk of venous thromboembolism, which anticoagulants are intended to reduce. But…
View Post 8 min This content is machine translated Pregnancy and birth with congenital heart defect Relevant for the practice Despite all medical advances, corrected congenital heart defects (AHF) are not “cured” heart defects. In the long-term course, cardiovascular problems such as cardiac arrhythmias, heart failure or pulmonary hypertension may…
View Post 6 min This content is machine translated Mechanical vaccination can save lives Atrial appendage closure in patients with atrial fibrillation More than 95% of all emboli in patients with atrial fibrillation originate in the left atrial ear. Atrial appendage closure can be performed by means of a 20-minute procedure under…
View Post 8 min This content is machine translated Therapy update on atrial fibrillation Important concepts and new paradigms in the treatment of atrial fibrillation. Atrial fibrillation is a dynamic arrhythmia that requires individual and broad investigations and therapeutic approaches. Comprehensive treatment of atrial fibrillation patients is based on five pillars: 1. prevention of thromboembolic…
View Post 6 min This content is machine translated Symposium Interventional Cardiology Too much of a good thing or not enough? The Interventional Cardiology Symposium at the University Hospital Zurich was also dedicated to anticoagulants and antiplatelet agents. Here, the question was “one, two, or three?” As it turned out, the…
View Post 6 min This content is machine translated Medidays: Update Hematology Anemia, new anticoagulants, and CLL. At Medidays, the internal medicine training program of the University Hospital Zurich (USZ), presentations were also given on various hematology topics. How is anemia meaningfully clarified? Which patients should be…
View Post 7 min This content is machine translated Follow-up after heart surgery and intervention Which valve needs to be anticoagulated and how? There is clear evidence for oral anticoagulation in mechanical valves. However, individual adjustments of the target INR are sometimes necessary. Moreover, additional platelet inhibition to OAK is becoming routine. The…
View Post 8 min This content is machine translated Atrial fibrillation What is the indication for anticoagulation and arrhythmia? Atrial fibrillation is the most common sustained arrhythmia. The prevalence in the general population is 1.5-2% [1]. With a fivefold increased risk of stroke and threefold increased risk of cardiac…
View Post 9 min This content is machine translated New oral anticoagulants 10 questions from daily use The new oral anticoagulants (NOAKs) have long since become part of everyday clinical practice in stroke prophylaxis for atrial fibrillation. Due to their simpler, safer, and effective use, they are…
